The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
(Q64388522)
article
article
Language:
Current Data About
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
| (P31) |
(Q13442814)
|
||||||||||
| (P304) |
23899-903
|
||||||||||
| (P407) |
(Q1860)
|
||||||||||
| (P433) |
31
|
||||||||||
| (P478) |
275
|
||||||||||
| (P577) |
Friday, August 4, 2000
|
||||||||||
| (P921) |
(Q412415)
(Q128581)
|
||||||||||
| (P1433) |
(Q867727)
|
||||||||||
| (P1476) |
"The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin" (language: en)
|
||||||||||
| (P2093) |
A Bhattacharyya
U S Ear
B H Koller
R R Weichselbaum
D K Bishop
|